Midday Report: Aclaris (ACRS) Trades Higher August 5

Equities Staff  |

Aclaris Therapeutics Inc (NASDAQ: ACRS) shares moved 23.82%, or $3.43 per share, as on 11:43:47 est today. After Opening the Day at $16.42, 110,466 shares of Aclaris have traded hands and the stock has moved between $18.10 and $16.29.  

So far this year the company has moved YTD 15.34%.

Aclaris is set to release earnings on 2022-11-02.

For technical charts, analysis, and more on Aclaris visit the company profile.

About Aclaris Therapeutics Inc

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.

To get more information on Aclaris Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Aclaris Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan
The Strong Dollar Is a Problem for Stocks

Market Movers

Sponsored Financial Content